Newsroom | 5233 results

DENVER--(BUSINESS WIRE)--Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals, a national survey of U.S. adults that examines Americans' evolving attitudes and behaviors toward GLP-1 medications. While GLP-1 medications have become one of the most visible health trends in America, this year’s report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one, revealing a surprising gap between public...

DENVER--(BUSINESS WIRE)--Strive Health, the national leader in value-based kidney care, has welcomed two new members to its executive team. Jamie Sharp, M.D., has been named chief medical officer and will oversee Strive’s clinical strategy and performance. Serving as chief financial officer, Chris Rigg will drive financial strategy and operations, while helping scale the business and deploy AI technologies.“As we continue to build on Strive’s strong momentum, Jamie and Chris stood out as the rig...

TORONTO & NEW YORK--(BUSINESS WIRE)--Researchers at Klick Labs are launching a series of clinical studies with Mayo Clinic in Florida exploring the use of novel vocal biomarkers....

MENLO PARK, Calif.--(BUSINESS WIRE)--OrsoBio presents positive Phase 2a data for its LXR inverse agonist TLC-2716 in SHTG and MASLD at ENDO 2026....

SAN FRANCISCO--(BUSINESS WIRE)--CMHC (Cardiometabolic Health Congress), the premier forum where evidence-based innovation meets clinical practice, unveils the 2026 Conference Program. For over two decades, CMHC has united healthcare providers from around the globe to transform cutting-edge research into actionable strategies that enhance patient care. CMHC uniquely bridges the gap between groundbreaking science and real-world application, empowering a global community of clinicians to transform...

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics®, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its mammalian cell culture capabilities with the addition of cell line development services, strengthening its ability to provide a seamless path from DNA to IND submission for its customers. The launch of new cell line development services reflects Cytovance’s continued investment in innovati...

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced an expanded menu of GLP-1 fulfillment options for employers, spanning pharmacy benefit manager (PBM), direct-to-employer (DTE), and direct-to-consumer (DTC) solutions. Virta pairs these fulfillment options with its proven Responsible Prescribing and Nutrition-first weight loss programs through which members, regardless of the fulfillment option, receive Virta’s in-house provider oversight and perso...

SAN FRANCISCO--(BUSINESS WIRE)--Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development...

MANHASSET, N.Y.--(BUSINESS WIRE)--After four years of dedicated work alongside community partners, Northwell Health has been recognized by the Centers for Disease Control and Prevention (CDC) as an Umbrella Hub Organization (UHO) for the National Diabetes Prevention Program (NDPP). This designation positions Northwell to dramatically expand access to diabetes prevention services and facilitate reimbursement from Medicare, Medicaid and other payers in New York, ensuring the sustainability and gr...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on advancing stem cell-derived pancreatic cell therapies for type 1 diabetes. Under the collaboration, the teams seek to define and develop an allogeneic pancreatic beta cell therapy for insulin-dependent diabetes based on patient needs. Syntax Bio plans to use its proprietary CellgorithmTM platform to gui...